Market Research Report - 239841
Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors
|Published by||BioSeeker Group AB|
|Published||Content info||4724 Pages|
|Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors|
|Published: June 12, 2013||Content info: 4724 Pages||
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.